Maurizio Rossini

Prof. Maurizio Rossini

Rheumatology Unit, University of Verona
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in The American Journal of Medicine
Verified
Journal Article
Closed access
JCJuliet E. Compston
Juliet E. Compston
NWNelson B. Watts
Nelson B. Watts
RCRoland Chapurlat
Roland Chapurlat
CCCyrus Cooper
Cyrus Cooper
SBSteven Boonen
Steven Boonen
ESEthel S. Siris
Ethel S. Siris

13 June 2018 in Internal and Emergency Medicine
Verified
Journal Article
Open access
PDF file
RNRanuccio Nuti
Ranuccio Nuti
Maria Luisa BrandiMaria Luisa Brandi
Maria Luisa Brandi
GCGiovanni Checchia
Giovanni Checchia
OMOmbretta Di Munno
Ombretta Di Munno
LDLigia Dominguez
Ligia Dominguez
GIGiovanni Carlo Isaia
Giovanni Carlo Isaia
The purpose of this document, a result of the harmonisation and revision of Guidelines published separately by the SIMFER, SIOMMMS/SIR, and SIOT associations, is to provide practical indications based on specific levels of evidence and various grades of recommendations, drawn from available literature, for the management of osteoporosis and for the diagnosis, prevention, and treatment of fragility fractures. These indications were discussed and formally approved by the delegates of the Italian Scientific Associations involved in the project (SIE, SIGG, SIMFER, SIMG, SIMI, SIOMMMS, SIR, and SIOT).

23 June 2016 in Reumatismo
Verified
Journal Article
Open access
PDF file
MRMaurizio Rossini
Maurizio Rossini
SAS. Adami
S. Adami
FBF. Bertoldo
F. Bertoldo
DDDaniele Diacinti
Daniele Diacinti
DGD. Gatti
D. Gatti
GIG. C. Isaia
G. C. Isaia
Osteoporosis poses a significant public health issue. National Societies have developed Guidelines for the diagnosis and treatment of this disorder with an effort of adapting specific tools for risk assessment on the peculiar characteristics of a given population. The Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) has recently revised the previously published Guidelines on the diagnosis, riskassessment, prevention and management of primary and secondary osteoporosis. The guidelines were first drafted by a working group and then approved by the board of SIOMMMS. Subsequently they received also the endorsement of other major Scientific Societies that deal with bone metabolic disease. These recommendations are based on systematic reviews of the best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on leading experts’ experience and opinion, and on good clinical practice. The osteoporosis prevention should be based on the elimination of specific risk factors. The use of drugs registered for the treatment of osteoporosis are recommended when the benefits overcome the risk, and this is the case only when the risk of fracture is rather high as measured with variables susceptible to pharmacological effect. DeFRA (FRAX® derived fracture risk assessment) is recognized as a useful tool for easily estimate the long-term fracture risk. Several secondary forms of osteoporosis require a specific diagnostic and therapeutic management.

11 June 2013 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
MRMaurizio Rossini
Maurizio Rossini
DGDavide Gatti
Davide Gatti
SASilvano Adami
Silvano Adami

15 March 2006 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
MRMaurizio Rossini
Maurizio Rossini
GBG. Bianchi
G. Bianchi
OMO. Di Munno
O. Di Munno
SGS. Giannini
S. Giannini
SMS. Minisola
S. Minisola
SAS. Adami
S. Adami

22 July 2013 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
JCJuliet E Compston
Juliet E Compston
JFJulie Flahive
Julie Flahive
DHDavid W Hosmer
David W Hosmer
NWNelson B Watts
Nelson B Watts
ESEthel S Siris
Ethel S Siris
FIfor the GLOW Investigators
for the GLOW Investigators
Low body mass index (BMI) is a well‐established risk factor for fracture in postmenopausal women. Height and obesity have also been associated with increased fracture risk at some sites. We investigated the relationships of weight, BMI, and height with incident clinical fracture in a practice‐based cohort of postmenopausal women participating in the Global Longitudinal study of Osteoporosis in Women (GLOW). Data were collected at baseline and at 1, 2, and 3 years. For hip, spine, wrist, pelvis, rib, upper arm/shoulder, clavicle, ankle, lower leg, and upper leg fractures, we modeled the time to incident self‐reported fracture over a 3‐year period using the Cox proportional hazards model and fitted the best linear or nonlinear models containing height, weight, and BMI. Of 52,939 women, 3628 (6.9%) reported an incident clinical fracture during the 3‐year follow‐up period. Linear BMI showed a significant inverse association with hip, clinical spine, and wrist fractures: adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) per increase of 5 kg/m2 were 0.80 (0.71–0.90), 0.83 (0.76–0.92), and 0.88 (0.83–0.94), respectively (all p < 0.001). For ankle fractures, linear weight showed a significant positive association: adjusted HR per 5‐kg increase 1.05 (1.02–1.07) (p < 0.001). For upper arm/shoulder and clavicle fractures, only linear height was significantly associated: adjusted HRs per 10‐cm increase were 0.85 (0.75–0.97) (p = 0.02) and 0.73 (0.57–0.92) (p = 0.009), respectively. For pelvic and rib fractures, the best models were for nonlinear BMI or weight (p = 0.05 and 0.03, respectively), with inverse associations at low BMI/body weight and positive associations at high values. These data demonstrate that the relationships between fracture and weight, BMI, and height are site‐specific. The different associations may be mediated, at least in part, by effects on bone mineral density, bone structure and geometry, and patterns of falling. © 2014 American Society for Bone and Mineral Research.